MAST THERAPEUTICS INC's ticker is MSTX and the CUSIP is 576314108. A total of 29 filers reported holding MAST THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $7,000 | +40.0% | 54,724 | 0.0% | 0.00% | – |
| Q4 2016 | $5,000 | -16.7% | 54,724 | 0.0% | 0.00% | – |
| Q3 2016 | $6,000 | 0.0% | 54,724 | +317.0% | 0.00% | – |
| Q2 2016 | $6,000 | +50.0% | 13,124 | 0.0% | 0.00% | – |
| Q1 2016 | $4,000 | -33.3% | 13,124 | 0.0% | 0.00% | – |
| Q4 2015 | $6,000 | -14.3% | 13,124 | 0.0% | 0.00% | – |
| Q3 2015 | $7,000 | +16.7% | 13,124 | 0.0% | 0.00% | – |
| Q2 2015 | $6,000 | 0.0% | 13,124 | 0.0% | 0.00% | – |
| Q1 2015 | $6,000 | -14.3% | 13,124 | 0.0% | 0.00% | – |
| Q4 2014 | $7,000 | -12.5% | 13,124 | -10.3% | 0.00% | – |
| Q3 2014 | $8,000 | -11.1% | 14,624 | 0.0% | 0.00% | – |
| Q2 2014 | $9,000 | -10.0% | 14,624 | 0.0% | 0.00% | – |
| Q1 2014 | $10,000 | -33.3% | 14,624 | -50.0% | 0.00% | – |
| Q4 2013 | $15,000 | +150.0% | 29,248 | +100.0% | 0.00% | – |
| Q3 2013 | $6,000 | 0.0% | 14,624 | 0.0% | 0.00% | – |
| Q2 2013 | $6,000 | – | 14,624 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JAY JEFFREY R | 5,800,000 | $2,490,000 | 1.97% |
| SABBY MANAGEMENT, LLC | 7,711,867 | $3,310,000 | 0.22% |
| Ancora Advisors LLC | 1,848,045 | $793,000 | 0.14% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,948,302 | $1,695,000 | 0.08% |
| Alyeska Investment Group, L.P. | 1,900,000 | $1,631,000 | 0.08% |
| Alyeska Investment Group, L.P. | 3,800,000 | $1,631,000 | 0.08% |
| SHEPHERD KAPLAN KROCHUK, LLC | 894,401 | $384,000 | 0.08% |
| PERKINS CAPITAL MANAGEMENT INC | 140,000 | $60,000 | 0.05% |
| Pine River Capital Management L.P. | 2,578,486 | $1,106,000 | 0.02% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 794,900 | $341,000,000 | 0.01% |